| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BEAM | Common Stock | Gift | $0 | -12K | -1.22% | $0.00 | 969K | Nov 16, 2021 | Direct | |
| transaction | BEAM | Common Stock | Sale | -$51.1K | -801 | -0.08% | $63.79 | 968K | Jan 31, 2022 | Direct | F2, F3 |
| transaction | BEAM | Common Stock | Sale | -$140K | -2.17K | -0.22% | $64.47 | 966K | Jan 31, 2022 | Direct | F2, F4 |
| transaction | BEAM | Common Stock | Sale | -$208K | -3.18K | -0.33% | $65.49 | 963K | Jan 31, 2022 | Direct | F2, F5 |
| transaction | BEAM | Common Stock | Sale | -$422K | -6.34K | -0.66% | $66.55 | 956K | Jan 31, 2022 | Direct | F2, F6 |
| transaction | BEAM | Common Stock | Sale | -$913K | -13.5K | -1.42% | $67.44 | 943K | Jan 31, 2022 | Direct | F2, F7 |
| transaction | BEAM | Common Stock | Sale | -$271K | -3.98K | -0.42% | $68.15 | 939K | Jan 31, 2022 | Direct | F2, F8 |
| transaction | BEAM | Common Stock | Options Exercise | $103K | +100K | +10.65% | $1.03* | 1.04M | Jan 31, 2022 | Direct | |
| transaction | BEAM | Common Stock | Sale | -$19K | -300 | -0.16% | $63.45 | 183K | Jan 31, 2022 | By John M. Evans, III 2018 Irrevocable Trust | F2, F9 |
| transaction | BEAM | Common Stock | Sale | -$104K | -1.62K | -0.88% | $64.46 | 181K | Jan 31, 2022 | By John M. Evans, III 2018 Irrevocable Trust | F2, F10 |
| transaction | BEAM | Common Stock | Sale | -$125K | -1.9K | -1.05% | $65.55 | 179K | Jan 31, 2022 | By John M. Evans, III 2018 Irrevocable Trust | F2, F11 |
| transaction | BEAM | Common Stock | Sale | -$273K | -4.11K | -2.29% | $66.48 | 175K | Jan 31, 2022 | By John M. Evans, III 2018 Irrevocable Trust | F2, F12 |
| transaction | BEAM | Common Stock | Sale | -$634K | -9.41K | -5.37% | $67.43 | 166K | Jan 31, 2022 | By John M. Evans, III 2018 Irrevocable Trust | F2, F13 |
| transaction | BEAM | Common Stock | Sale | -$182K | -2.67K | -1.61% | $68.16 | 163K | Jan 31, 2022 | By John M. Evans, III 2018 Irrevocable Trust | F2, F14 |
| holding | BEAM | Common Stock | 981K | Jan 31, 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BEAM | Stock Option (Right to Buy) | Options Exercise | $0 | -100K | -26.02% | $0.00 | 284K | Jan 31, 2022 | Common Stock | 100K | $1.03 | Direct | F15 |
| transaction | BEAM | Stock Option (Right to Buy) | Award | $0 | +113K | $0.00 | 113K | Jan 31, 2022 | Common Stock | 113K | $69.21 | Direct | F16 | |
| holding | BEAM | Stock Option (Right to Buy) | 384K | Jan 31, 2022 | Common Stock | $1.03 | Direct | F1, F15 |
| Id | Content |
|---|---|
| F1 | On each of July 7, 2021 and October 6, 2021, the reporting person filed a Form 4 which inadvertently reported an exercise of stock options in connection with certain sales of common stock. In fact, the reporting person did not exercise any stock options in connection with the sales reported on such Forms 4. Accordingly, the first line of each of Tables 1 and 2 of this Form 4 reflects the corrected number of securities beneficially owned by the reporting person prior to the transactions reported herein. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The sale price reported is a weighted average price. The reporting person undertakes to provide to Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.60 to $63.96, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.21 to $64.50, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.20 to $65.99, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.09 to $66.94, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.00 to $67.99, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.00 to $68.60, inclusive. |
| F9 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.26 to $63.58, inclusive. |
| F10 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $64.17 to $64.50, inclusive. |
| F11 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.20 to $65.99, inclusive. |
| F12 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $66.00 to $66.94, inclusive. |
| F13 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $67.00 to $67.99, inclusive. |
| F14 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $68.00 to $68.60, inclusive. |
| F15 | The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested. |
| F16 | The option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the reporting person's continued service with BEAM through each vesting date. |